GLP-1 and Obesity

Obesity affects over 1 billion people worldwide — or one in eight individuals — and has more than tripled in prevalence since 1975. The global economic impact is projected to surpass $4 trillion annually by 2030. Addressing this escalating crisis requires innovative, targeted solutions.

At SOLVD Health, we’re developing a test to enhance the effectiveness of GLP-1-based therapeutics — one of the fastest-growing treatments for obesity. Our goal is to enable personalized treatment by identifying individuals who are likely to respond best to specific GLP-1 medications and those who may not. By helping providers distinguish super responders from non-responders, we aim to improve patient outcomes and streamline treatment strategies.

Through our test, we’re committed to advancing a more precise and effective approach to chronic obesity management, empowering providers and patients alike to make informed, impactful decisions on the journey to better health.

.

Colon Cancer

Colon cancer is one of the most preventable forms of cancer — yet it’s the second leading cause of cancer deaths. We’re out to change that.

Through our partnership with Metabiomics, we’ve developed technology that detects biological signals associated with pre-cancerous polyps and colon cancer. Our noninvasive test analyzes an individual’s microbiome — the billions of bacteria and other microbes that live in the gut — to reveal subtle early signs of lesions that could become cancerous. We believe that through early detection and removal of these lesions, we may be able to prevent cancer before it starts. This test received FDA Breakthrough Device designation in August 2019.

Polycystic Ovary Syndrome

Polycystic ovary syndrome (PCOS) is a hormonal disorder that affects an estimated 5 to 6 million women of childbearing age — but many don’t know they have it. It’s time for that to change.

Because women with PCOS are at higher risk of infertility and metabolic syndrome, which leads to increased risk for heart disease, diabetes, and stroke, we’re developing new technology to help improve early detection and diagnosis of PCOS. Providing early, accurate insights about PCOS to providers and patients can help support early intervention and may help prevent other chronic conditions from developing.